Free Trial
NYSE:STE

STERIS (STE) Stock Price, News & Analysis

$226.81
-3.79 (-1.64%)
(As of 05/23/2024 ET)
Today's Range
$225.96
$230.76
50-Day Range
$198.94
$235.89
52-Week Range
$195.47
$254.00
Volume
635,803 shs
Average Volume
595,803 shs
Market Capitalization
$22.41 billion
P/E Ratio
59.37
Dividend Yield
0.92%
Price Target
$241.60

STERIS MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
6.5% Upside
$241.60 Price Target
Short Interest
Healthy
2.41% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.00
Upright™ Environmental Score
News Sentiment
0.99mentions of STERIS in the last 14 days
Based on 9 Articles This Week
Insider Trading
Selling Shares
$1.80 M Sold Last Quarter
Proj. Earnings Growth
8.88%
From $9.12 to $9.93 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.31 out of 5 stars

Medical Sector

115th out of 915 stocks

Surgical Appliances & Supplies Industry

7th out of 18 stocks

STE stock logo

About STERIS Stock (NYSE:STE)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

STE Stock Price History

STE Stock News Headlines

STERIS plc (NYSE:STE) VP Sells $267,312.56 in Stock
STERIS plc (NYSE:STE) VP Renato Tamaro Sells 1,154 Shares of Stock
STERIS's (STE) Neutral Rating Reiterated at Piper Sandler
Q4 2024 STERIS plc Earnings Call
Piper Sandler Reaffirms Their Hold Rating on Steris (STE)
STERIS Announces Dividend of $0.52 per share
See More Headlines
Receive STE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/22 Dividend
2/22/2024
Dividend Payable
3/22/2024
Last Earnings
5/08/2024
Today
5/23/2024
Ex-Dividend for 6/26 Dividend
6/12/2024
Dividend Payable
6/26/2024
Next Earnings (Estimated)
8/06/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Health Care Equipment
CUSIP
85915210
Employees
17,100
Year Founded
1987

Price Target and Rating

Average Stock Price Target
$241.60
High Stock Price Target
$265.00
Low Stock Price Target
$215.00
Potential Upside/Downside
+6.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
6 Analysts

Profitability

Net Income
$378.24 million
Pretax Margin
13.68%

Debt

Sales & Book Value

Annual Sales
$5.14 billion
Cash Flow
$9.69 per share
Book Value
$63.91 per share

Miscellaneous

Free Float
97,875,000
Market Cap
$22.41 billion
Optionable
Optionable
Beta
0.81

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

STE Stock Analysis - Frequently Asked Questions

Should I buy or sell STERIS stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" STE shares.
View STE analyst ratings
or view top-rated stocks.

What is STERIS's stock price target for 2024?

6 brokers have issued 12 month price objectives for STERIS's stock. Their STE share price targets range from $215.00 to $265.00. On average, they predict the company's share price to reach $241.60 in the next twelve months. This suggests a possible upside of 6.5% from the stock's current price.
View analysts price targets for STE
or view top-rated stocks among Wall Street analysts.

How have STE shares performed in 2024?

STERIS's stock was trading at $219.85 at the beginning of 2024. Since then, STE stock has increased by 3.2% and is now trading at $226.81.
View the best growth stocks for 2024 here
.

When is STERIS's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 6th 2024.
View our STE earnings forecast
.

How were STERIS's earnings last quarter?

STERIS plc (NYSE:STE) posted its earnings results on Wednesday, May, 8th. The medical equipment provider reported $2.58 earnings per share for the quarter, beating analysts' consensus estimates of $2.41 by $0.17. The medical equipment provider earned $1.42 billion during the quarter, compared to analysts' expectations of $1.41 billion. STERIS had a trailing twelve-month return on equity of 13.73% and a net margin of 6.95%. The firm's revenue for the quarter was up 10.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.30 earnings per share.
Read the conference call transcript
.

How often does STERIS pay dividends? What is the dividend yield for STERIS?

STERIS declared a quarterly dividend on Wednesday, May 1st. Investors of record on Wednesday, June 12th will be given a dividend of $0.52 per share on Wednesday, June 26th. This represents a $2.08 annualized dividend and a yield of 0.92%. The ex-dividend date is Wednesday, June 12th.
Read our dividend analysis for STE
.

Is STERIS a good dividend stock?

STERIS (NYSE:STE) pays an annual dividend of $2.08 per share and currently has a dividend yield of 0.90%. The company has been increasing its dividend for 19 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 54.45%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, STE will have a dividend payout ratio of 20.95% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for STE.

What guidance has STERIS issued on next quarter's earnings?

STERIS updated its FY25 earnings guidance on Wednesday, May, 8th. The company provided earnings per share (EPS) guidance of $9.05 to $9.25 for the period, compared to the consensus estimate of $9.33. The company issued revenue guidance of +6.5-7.5% yr/yr or $5.473 billion to $5.524 billion, compared to the consensus revenue estimate of $5.67 billion.

What is Walter M. Rosebrough, Jr.'s approval rating as STERIS's CEO?

196 employees have rated STERIS Chief Executive Officer Walter M. Rosebrough, Jr. on Glassdoor.com. Walter M. Rosebrough, Jr. has an approval rating of 79% among the company's employees.

What other stocks do shareholders of STERIS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STERIS investors own include Johnson & Johnson (JNJ), Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT).

Who are STERIS's major shareholders?

STERIS's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (11.98%), WCM Investment Management LLC (4.79%), Janus Henderson Group PLC (2.03%), Price T Rowe Associates Inc. MD (1.76%), Sustainable Growth Advisers LP (1.50%) and Champlain Investment Partners LLC (1.05%). Insiders that own company stock include Cary L Majors, Cynthia L Feldmann, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Michael J Tokich, Mohsen Sohi and Renato Tamaro.
View institutional ownership trends
.

How do I buy shares of STERIS?

Shares of STE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:STE) was last updated on 5/24/2024 by MarketBeat.com Staff

From Our Partners